IOL Chemicals and Pharmaceuticals DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.75×	0.75×	0.73×	0.74×	0.74×
	0.99×	0.98×	1.06×	1.08×	1.05×
	9.1%	8.1%	6.3%	7.9%	8.1%
	0.93×	0.93×	0.90×	1.00×	1.11×
	1.44×	1.44×	1.41×	1.39×	1.34×
	8.9%	7.9%	6.2%	8.8%	9.3%
	7.9%	7.9%	6.1%	8.6%	9.6%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

IOLCP₹184.93

IOL Chemicals and Pharmaceuticals Limited

· Pharma & Health

₹ CrorePeersMOREPENLAB FDC INNOVACAP ORCHPHARMA SENORES SANOFI GUJTHEM RPGLIFEMcap ₹5,429 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.74	0.74	0.73	0.75	0.75
Interest Burden (Pretax/EBIT) ×	1.05	1.08	1.06	0.98	0.99
EBIT Margin %	8.10	7.86	6.27	8.14	9.06
Asset Turnover ×	1.11	1.00	0.90	0.93	0.93
Financial Leverage (Assets/Equity) ×	1.34	1.39	1.41	1.44	1.44
ROE (5-step product, year-end total equity) %	9.34	8.78	6.17	7.94	8.91
ROE (owners' profit / average owners' equity) %	9.60	8.62	6.13	7.90	7.90

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.